Alena Zindel

SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma.

L. Staudt, C. Schmitt, K. Stegmaier, 2020, Blood.

The proteogenomic subtypes of acute myeloid leukemia.

J. Cox, F. Buettner, A. Trumpp, 2022, Cancer cell.

Repository of the Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association

L. Staudt, C. Schmitt, K. Stegmaier, 2023 .

Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy.

L. Staudt, A. Shaffer, Hong Zhao, 2024, Cancer cell.